| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 194,472 | 193,971 |
| Effect of foreign exchange rate changes on cash and cash equivalents | -41 | 23 |
| Net increase (decrease) in cash and cash equivalents | 63,174 | 212,247 |
| Cash and cash equivalents at beginning of period | 35,723 | - |
| Cash and cash equivalents at end of period | 98,897 | - |
Nuvation Bio Inc. (NUVB)
Nuvation Bio Inc. (NUVB)